Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 3.33
-3.76 %
$ 58.7 M
Market Cap
-3.54
P/E
XGN - STOCK-BASED COMPENSATION
Stock-based Compensation XGN - Exagen Inc.
3.62 M
LAST VALUE
-12.53%
2 YEAR CAGR
99.66%
5 YEAR CAGR
41.06%
10 YEAR CAGR